Global Insulin Delivery Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Global Insulin Delivery Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

  • Healthcare
  • Upcoming Reports
  • Sep 2024
  • Global
  • 350 Seiten
  • Anzahl der Tabellen: 50
  • Anzahl der Abbildungen: 250

Global Insulin Delivery Devices Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2024 –2031
Diagramm Marktgröße (Basisjahr)
USD 14.56 Billion
Diagramm Marktgröße (Prognosejahr)
USD 26.76 Billion
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • BD
  • Medtronic
  • F. Hoffmann-La Roche Ltd
  • Lily
  • YPSOMED

Global Insulin Delivery Devices Market Segmentation, By Product Type (Insulin Pens, Insulin Pumps, Pen Needles, Insulin Syringes, Insulin Injectors, Others), Application (Type I Diabetes, Type II Diabetes), End User (Hospitals and Clinics, Homecare, Specialty Centers), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/Centers) – Industry Trends and Forecast to 2031.

Insulin Delivery Devices Market

Insulin Delivery Devices Market Analysis

Insulin refers to a blood-sugar regulating hormone that plays a crucial role in the treatment of diabetes. Individuals who are suffering from diabetes use one of the available insulin delivery devices for accessing an insulin dose. The rise in awareness regarding diabetes is escalating the growth of insulin delivery devices market.

Insulin Delivery Devices Market Size

Global insulin delivery devices market size was valued at USD 14.56 billion in 2023 and is projected to reach USD 26.76 billion by 2031, with a CAGR of 7.90% during the forecast period of 2024 to 2031.

Report Scope and Market Segmentation       

Attributes

Insulin Delivery Devices Key Market Insights

Segmentation

  • By Product Type: Insulin Pens, Insulin Pumps, Pen Needles, Insulin Syringes, Insulin Injectors, Others
  • By Application: Type I Diabetes, Type II Diabetes
  • By End User: Hospitals and Clinics, Homecare, Specialty Centers
  • By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/Centers

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Key Market Players

BD (US), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Lily. (US), YPSOMED (Switzerland), Novo Nordisk A/S (Denmark), Beta Bionics, Inc. (US), Owen Mumford Ltd. (UK), Sanofi (France), B. Braun Melsungen AG (Germany), Abbott (US), Tandem Diabetes Care, Inc. (US), Copernicus (Poland), Insulet Corporation (US), West Pharmaceutical Services, Inc. (US), InsuJet (Netherlands), SHL Medical AG (Switzerland), SOOIL Developments Co., Ltd. (South Korea), and Johnson & Johnson Services, Inc. (US), among others

Insulin Delivery Devices Market Definition

The consumption of insulin is not possible in the form of a tablet or a swallowed in liquid form, as it tends to get degenerated by digestive enzymes and juices when it reaches bloodstream. Thus, the infusion or injection is usually processed into the fatty tissue. Wide range of devices are used to deliver insulin to the target location, including insulin pumps, jet injectors, syringes and jet injectors. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Insulin Delivery Devices Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

  • Diabetic Population

The increase in the number of people suffering from diabetes across the globe acts as one of the major factors driving the growth of insulin delivery devices market.

  • Favorable Reimbursement Scenario

The presence of favorable reimbursement environment and government support in selected countries accelerate the market.

  • Surge in Health Expenditure

The surge in the diabetes-related health expenditure in emerging economies further influence the insulin delivery devices market.

  • Awareness about Insulin Delivery Devices

The increase in the conferences, meetings, and congresses for rising awareness about insulin delivery devices will assist in the expansion of the market.

Opportunities

Furthermore, rise in research and development activities extend profitable opportunities to the market players in the forecast period of 2024 to 2031. Also, technological advancements in insulin delivery devices will assist in the expansion of the market.

Restraints/Challenges

On the other hand, issues associated with the reuse of pen needles and infusion sets and poor reimbursement structure in developing countries are expected to obstruct market growth. Also, needle anxiety in patients and oral insulin as an alternative drug delivery method are projected to challenge the insulin delivery devices market in the forecast period of 2024-2031.

This insulin delivery devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on insulin delivery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Insulin Delivery Devices Market

The COVID-19 pandemic had a big impact on the insulin delivery devices market both, positively ane negatively. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. However, healthcare organizations were preparing new plans to respond growing COVID-19 patients, such as sourcing rapid diagnosing kits to sufficient PPE kits for workers. Diabetic populace had to take extra precautions as they are at higher risk of acquiring an infection. The market was not affected harshly as insulin injection is essential for patients suffering from diabetes.

Global Insulin Delivery Devices Market Scope

The insulin delivery devices market is segmented on the basis of product type, application, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Insulin Pens
    • Reusable Insulin Pens
    • Disposable Insulin Pens
  • Insulin Pumps
    • External/Tethered Pumps
    • Patch Pumps
  • Pen Needles
    • Standard Pen Needles
    • Safety Pen Needles
  • Insulin Syringes
  • Insulin Injectors
  • Others

Application

  • Type I Diabetes
  • Type II Diabetes

End User

  • Hospitals and Clinics
  • Homecare
  • Specialty Centers

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Diabetes Clinics/Centers

Insulin Delivery Devices Market Regional Analysis

The insulin delivery devices market is analysed and market size insights and trends are provided by country, product type, application, end user and distribution channel as referenced above.

The countries covered in the insulin delivery devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the insulin delivery devices market because of the prevalence of diabetes and favorable reimbursement scenario within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2024 to 2031 due to the rise in patient awareness toward disease in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The insulin delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for insulin delivery devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the insulin delivery devices market. The data is available for historic period 2010-2020.

Insulin Delivery Devices Market Share

The insulin delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to insulin delivery devices market.

Insulin Delivery Devices Market Leaders Operating in the Market Are:

  • BD (US)
  • Medtronic (Ireland)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Lily. (US)
  • YPSOMED (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Beta Bionics, Inc. (US)
  • Owen Mumford Ltd. (UK)
  • Sanofi (France)
  • B. Braun Melsungen AG (Germany)
  • Abbott (US)
  • Tandem Diabetes Care, Inc. (US)
  • Copernicus (Poland)
  • Insulet Corporation (US)
  • West Pharmaceutical Services, Inc. (US)
  • InsuJet (Netherlands)
  • SHL Medical AG (Switzerland)
  • SOOIL Developments Co., Ltd. (South Korea)
  • Johnson & Johnson Services, Inc. (US)

Latest Development in Insulin Delivery Devices Market

  • The Brazilian National Health Surveillance Agency (ANVISA) gave registration certificates insulin glargine injection and insulin glargine injection (prefilled pen) by Gan & Lee in 2020. the first shipments of these insulin injections were successfully delivered to Brazil in the early of 2021


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The market is segmented based on Segmentation, By Product Type (Insulin Pens, Insulin Pumps, Pen Needles, Insulin Syringes, Insulin Injectors, Others), Application (Type I Diabetes, Type II Diabetes), End User (Hospitals and Clinics, Homecare, Specialty Centers), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/Centers) – Industry Trends and Forecast to 2031. .
The Global Insulin Delivery Devices Market size was valued at USD 14.56 USD Billion in 2023.
The Global Insulin Delivery Devices Market is projected to grow at a CAGR of 7.9% during the forecast period of 2024 to 2031.
The major players operating in the market include BD, Medtronic, F. Hoffmann-La Roche Ltd, Lily, YPSOMED, Novo Nordisk A/S, Beta Bionics , Owen Mumford , Sanofi, B. Braun Melsungen AG, Abbott, Tandem Diabetes Care , Copernicus, Insulet Corporation, West Pharmaceutical Services , InsuJet, SHL Medical AG, SOOIL Developments Co. , Johnson & Johnson Services .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.